Community Health Systems

Community Health Systems R&D Expenses

The Research & Development Expenses of Community Health Systems (CYH) as of Nov 19, 2026 is 80.00 M USD. In the previous year, Research & Development Expenses was 85.00 M USD — a change of -5.88% (lower).

R&D Expenses

80.00 MUSD

YoY

-5.88%

Last updated:

Research & Development Expenses of Community Health Systems is 2023 80.00 M USD. Research & Development Expenses of Community Health Systems was 2022 85.00 M USD. It decreases by -5.88% lower compared to the previous year.

The Community Health Systems R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2021
108.00 M USD
Jan 1, 2022
85.00 M USD
Jan 1, 2023
80.00 M USD
The Community Health Systems R&D Expenses history
YEARR&D ExpensesYoY
80.00 MUSD-5.88%
85.00 MUSD-21.30%
108.00 MUSD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Community Health Systems Stock analysis

What does Community Health Systems do? Community Health Systems Inc., also known as CHS, is a healthcare company operating in the United States. It was founded in 1985 by businessmen Richard Scrushy and Wayne Smith and is headquartered in Franklin, Tennessee. The company's business model involves acquiring and operating hospitals and medical facilities. CHS primarily focuses on meeting the need for medical services in communities that lack adequate care. It also builds new medical facilities to improve patient care and drive growth. In its early years, CHS mainly acquired and operated hospitals in rural areas that struggled to treat patients due to limited resources. However, the company later shifted its focus to urban areas, forming partnerships with healthcare organizations and acquiring hospitals. CHS is divided into different divisions, including acute hospitals, long-term care facilities for elderly patients, and surgical clinics and outpatient facilities. The products offered by CHS depend on the respective divisions and include diagnostic tests and procedures, therapy and rehabilitation services, and medical devices and equipment. Overall, CHS plays a vital role in providing quality care to patients in both rural and urban communities, and it has earned a good reputation in the healthcare industry. Community Health Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Community Health Systems stock

Research & Development Expenses of Community Health Systems is 80.00 M USD in 2023.

Research & Development Expenses of Community Health Systems changed from 85.00 M USD to 80.00 M USD, representing a -5.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Community Health Systems since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Community Health Systems historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Community Health Systems

All Key Metrics — Community Health Systems